Geopolitics Alpha

Live · last trade · ETF proxies, Alpaca IEX

Insmed shares jump more than 6% on report Sanofi is weighing acquisition

Published . Updated .

Key takeaways

  • This report does not map to a usual set of affected companies.
  • Exposed: INSM, SNY, XLV, LLY, JNJ
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest and never sell or share it. See our privacy policy.

GEOPOLITICS ALPHAInsmed shares jump more than 6% onreport Sanofi is weighingacquisitionINSMSNYGEOPOLITICS ALPHA

This report does not map to a usual set of affected companies.

Directly affected

  • INSM Insmed+12.2% 30d

    Named in this report.

  • SNY Sanofi

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Insmed belongs to, so it often moves with news about it.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.

  • ABBV AbbVie+12.0% 30d

    AbbVie is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.

  • MRK Merck+3.5% 30d

    Merck is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.

  • ABT Abbott Laboratories+10.0% 30d

    Abbott Laboratories is a peer of Insmed in pharmaceutical preparations; rivals often move on the same news.

  • NVS Novartis AG

    Novartis AG is a peer of Sanofi in pharmaceutical preparations; rivals often move on the same news.

  • AZN AstraZeneca+19.9% 30d

    AstraZeneca is a peer of Sanofi in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
INSMPrices arriving within minutes———after closeafter closeafter closeafter close
SNYPrices arriving within minutes———after closeafter closeafter closeafter close
XLVPrices arriving within minutes———after closeafter closeafter closeafter close
LLYPrices arriving within minutes———after closeafter closeafter closeafter close
JNJPrices arriving within minutes———after closeafter closeafter closeafter close
ABBVPrices arriving within minutes———after closeafter closeafter closeafter close
MRKPrices arriving within minutes———after closeafter closeafter closeafter close
ABTPrices arriving within minutes———after closeafter closeafter closeafter close
NVSPrices arriving within minutes———after closeafter closeafter closeafter close
AZNPrices arriving within minutes———after closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Insmed shares jump more than 6% on report Sanofi is weighing acquisition Investing.com

Source: Investing.com

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“Insmed shares jump more than 6% on report Sanofi is weighing acquisition” scores 12 out of 100. The score uses 1 source.